Tools


Site Haritası

Site Haritası

Quantitative Whole-Body MRI

In his Editorial “Advancing Cancer Care with Modern MRI”203kB Professor Padhani points out that many aspects of cancer care remain on ‘red alert’ as we enter the second decade of the 21st century. There are many times when healthcare professionals cannot confidently answer questions that directly affect patient care. Seemingly simple questions such as “Do I have cancer?”, “Is the cancer going to kill me?”, “Is my cancer responding to therapy?”, “Is the cancer back?” and “How long do I have to live?”, “Will I make it to my daughter’s wedding?” evade us on a daily basis. While we struggle to respond to the needs of our patients, we remain aware that progress is being made every day in cancer diagnosis and therapy, and within this, is the role being played by MRI as highlighted by articles and videos on this page.

 

Watching Cancer Develop Multidrug Resistance

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Observing Endocrine Therapy Resistance in Metastatic Breast Cancer with Whole-body MRI - Padhani

Observing Endocrine Therapy Resistance in Metastatic Breast Cancer with Whole-body MRI

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Metastatic Prostate Cancer in Practice The MET-RADS-P Imaging Response System Using Whole-body MRI - Padhani

Metastatic Prostate Cancer in Practice The MET-RADS-P Imaging Response System Using Whole-body MRI

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
Nina Tunariu, Royal Marsden NHS Foundation Trust & Institute of Cancer Research and Cancer Research UK Cancer Imaging Centre, Sutton, Surrey, UK
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Monitoring Bone Marrow Metastases Treatment with Whole-Body Diffusion MRI - Padhani

Monitoring Bone Marrow Metastases Treatment with Whole-Body Diffusion MRI

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Whole Body Diffusion-Weighted MRI for Bone Marrow Tumor Detection - Padhani

Whole Body Diffusion-Weighted MRI for Bone Marrow Tumor Detection

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Initial Experience with Whole-Body Diffusion-Weighted Imaging in Oncological and Non-Oncological Patients - Bittencourt

Initial Experience with Whole-Body Diffusion-Weighted Imaging in Oncological and Non-Oncological Patients

Leonardo Kayat Bittencourt, Clínica de Diagnóstico por Imagem, Rio de Janeiro, Brazil
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Whole-Body Diffusion-Weighted MRI of the Bone Marrow in Health and Disease - Padhani

Whole-Body Diffusion-Weighted MRI of the Bone Marrow in Health and Disease

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - 18F-FDG PET/MR: Its Incremental Value in Assessing the Multiple Myeloma Patient - Shah

18F-FDG PET/MR: Its Incremental Value in Assessing the Multiple Myeloma Patient

Shetal N. Shah, M.D., Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Hybird PET/MR Imaging with PSMA-Ligands: The Future Standard in the Diagnosis of Prostate Cancer? - Afshar-Oromieh
 

Hybird PET/MR Imaging with PSMA-Ligands: The Future Standard in the Diagnosis of Prostate Cancer?

Ali Afshar-Oromieh, M.D., Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Combining [18F] PET with MR for Detection of Bone Metastases in One Simultaneous Examination - Lentschig

Combining [18F] PET with MR for Detection of Bone Metastases in One Simultaneous Examination

Markus Lentschig, CEMODI, Centre for Modern Diagnostics, Bremen, Germany
 


Product News

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Whole-body Diffusion-weighted MR Image Analysis with syngo.via Frontier MR Total Tumor Load - Grimm

Whole-body Diffusion-weighted MR Image Analysis with syngo.via Frontier MR Total Tumor Load

Robert Grimm, Siemens Healthineers, Erlangen, Germany
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Whole-body MR Image Reading and Bone Assessment with syngo.via Frontier MR Bone Scan - Fenchel
 

Whole-body MR Image Reading and Bone Assessment with syngo.via Frontier MR Bone Scan

Matthias Fenchel, Siemens Healthineers, Erlangen, Germany
 


Application Tips

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - How-I-do-it: Whole-body MRI including DWI - Hillier

How-I-do-it: Whole-body MRI including DWI

David Hillier, MR Application Specialist, Siemens Healthineers Great Britain and Ireland
 

Siemens - MRI - MAGNETOM World - Hot Topics - Quantitative Whole-Body MRI - Frequently Asked Questions: Diffusion-Weighted Imaging - Graessner

Frequently Asked Questions: Diffusion-Weighted Imaging

Joachim Graessner, Dipl. Ing., Siemens Healthineers, Hamburg, Germany
 

Bu bilgi yardımcı oldu mu?
Yanıtınız için teşekkür ederiz
Yorumunuzda sayı ve/veya '@' işareti olduğunu fark ettik. Sizinle iletişime geçmemiz için telefon numarası ya da e-posta adresi girmeye çalışıyorsanız lütfen bizimle e-posta formumuz aracılığıyla iletişime geçiniz.

Not: Doğrudan kişisel bir yanıt almak için lütfen bizimle e-posta formumuz üzerinden iletişime geçiniz.

Teşekkür ederiz